10.25384/SAGE.6802394.v1
Messoud Ashina
Messoud
Ashina
Stewart Tepper
Stewart
Tepper
Jan Lewis Brandes
Jan Lewis
Brandes
Uwe Reuter
Uwe
Reuter
Guy Boudreau
Guy
Boudreau
David Dolezil
David
Dolezil
Sunfa Cheng
Sunfa
Cheng
Feng Zhang
Feng
Zhang
Robert Lenz
Robert
Lenz
Jan Klatt
Jan
Klatt
Daniel D Mikol
Daniel D
Mikol
Supplementary table 1 -Supplemental material for Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
SAGE Journals
2018
Erenumab
chronic migraine
clinical trial of prophylactic migraine treatment
prior preventive treatment failure
prior prophylactic treatment failure
2018-07-08 12:00:00
Journal contribution
https://sage.figshare.com/articles/journal_contribution/Supplementary_table_1_-Supplemental_material_for_Efficacy_and_safety_of_erenumab_AMG334_in_chronic_migraine_patients_with_prior_preventive_treatment_failure_A_subgroup_analysis_of_a_randomized_double-blind_placebo-controlled_study/6802394
<p>Supplemental material, Supplementary table 1 for Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study by Messoud Ashina, Stewart Tepper, Jan Lewis Brandes, Uwe Reuter, Guy Boudreau, David Dolezil, Sunfa Cheng, Feng Zhang, Robert Lenz, Jan Klatt and Daniel D Mikol in Cephalalgia</p>